Phage Safety Retrospective Cohort Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHospices Civils de Lyon
About this trial
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Eligibility criteria
Qualifiers
patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event
Disqualifiers
None
Trial design
Treatments tested in this trial
- patients having had avderse event after phagotherapy for bone or joint or implant infection
Treatment groups
25 Participants
are divided into 1 treatment groupLocations
1Hospices Civils de Lyon69004, Lyon France
Sponsors and collaborators
Hospices Civils de Lyon
Lead sponsor
Source ClinicalTrials.gov